Buffalo (NY) - Scientists at the Andrei Roswell Park Cancer institute in Buffalo New York say they successfully stopped radiation damage with a new drug. Called CBLB502, the drug is derived from Salmonella proteins and prevents cell suicide or aptosis.
So far the drug has worked well in tests with mice and monkeys, but the Department of Defense feels confident it can be adapted into a human-friendly form and has granted the developing company a $9 million dollar contract.
The results have been published in the journal of Science.
Read more ... Reuters.
More about tech industry
